Brief: RepliCel announces granting of 2 patents in Europe
Feb 9 (Reuters) - Replicel Life Sciences Inc RP.V
* Announced granting of two patents in Europe related to its
multi-needle dermal injection technologies
Source text for Eikon: ID:nPnbHCZY4a
Further company coverage: RP.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector